v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ 576,824 $ (446,315)
Reconciling items:    
Depreciation 162,943 167,170
Amortization of Intangibles Assets and Indefinite Lived Intangibles Impairment 155,546 146,588
Amortization of non-recoupable ticketing contract advances 56,121 49,214
Amortization of debt issuance costs and discounts 12,333 27,916
Stock-based compensation expense 86,178 80,165
Unrealized changes in fair value of contingent consideration 23,601 (6,998)
Equity in losses of nonconsolidated affiliates, net of distributions 31,420 6,396
Provision for uncollectible accounts receivable 40,736 (14,006)
Gain (Loss) on Sale of Investments 393 83,580
Other, net (10,596) 6,380
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable (1,009,472) (690,105)
Increase in prepaid expenses and other assets (297,379) (92,635)
Increase in accounts payable, accrued expenses and other liabilities 1,536,196 1,323,448
Increase (decrease) in deferred revenue (435,701) 551,059
Net cash provided by operating activities 928,357 1,024,697
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances of notes receivable (58,307) (24,476)
Collections of notes receivable 16,473 16,500
Investments made in nonconsolidated affiliates (73,335) (55,246)
Purchases of property, plant and equipment (205,987) (103,914)
Cash paid for acquisitions, net of cash acquired (38,770) (19,594)
Purchases of intangible assets (6,764) (6,681)
Proceeds from Sale of Long-term Investments 3,863 80,593
Other, net 3,099 1,059
Net cash used in investing activities (359,728) (111,759)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from long-term debt, net of debt issuance costs 5,750 904,164
Payments on long-term debt (29,462) (93,168)
Contributions from noncontrolling interests 14,340 15,985
Distributions to noncontrolling interests (81,852) (25,632)
Purchases and sales of noncontrolling interests, net (27,104) (3,273)
Proceeds from sale of common stock, net of issuance costs 0 449,415
Proceeds from exercise of stock options 35,698 30,322
Taxes paid for net share settlement of equity awards (46,953) (42,731)
Payments for deferred and contingent consideration (45,164) (12,845)
Other, net (472) 84
Net cash provided by (used in) financing activities (175,219) 1,222,321
Effect of exchange rate changes on cash, cash equivalents and restricted cash (325,011) (48,501)
Net increase in cash, cash equivalents, and restricted cash 68,399 2,086,758
Cash, cash equivalents, and restricted cash at beginning of period 4,887,792 2,546,439
Cash, cash equivalents, and restricted cash at end of period $ 4,956,191 $ 4,633,197

Source